News
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC)Spero ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback